Zai Lab (ZLAB) Current Deferred Revenue (2017 - 2022)

Zai Lab (ZLAB) has reported Current Deferred Revenue for 6 consecutive years, with $26.9 million the latest figure, recorded in Q1 2022.

• Quarterly Current Deferred Revenue rose 61.47% year-over-year to $26.9 million in Q1 2022, while the trailing twelve-month figure through Mar 2022 was $26.9 million (up 61.47% YoY) and the FY2021 annual result came in at $27.5 million, up 63.04% from the prior year.
• Current Deferred Revenue eased to $26.9 million in Q1 2022 per ZLAB's latest filing, from $27.5 million in the prior quarter.
• Over the last five years, Current Deferred Revenue for ZLAB reached as high as $27.5 million in Q4 2021 and fell as low as $2.1 million in Q4 2018.
• A 5-year average of $14.6 million and a median of $16.8 million in 2020 frame the typical range for Current Deferred Revenue.
• Annual changes were most pronounced in 2018 — Current Deferred Revenue slipped 13.79% — and 2020, when it jumped 485.14%.
• Year by year, Current Deferred Revenue stood at $2.1 million in 2018, then soared by 39.58% to $2.9 million in 2019, then soared by 485.14% to $16.9 million in 2020, then jumped by 63.04% to $27.5 million in 2021, then decreased by 2.15% to $26.9 million in 2022.
• According to Business Quant data, Current Deferred Revenue over the past three periods registered $26.9 million, $27.5 million, and $17.5 million for Q1 2022, Q4 2021, and Q3 2021 respectively.